Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Tax Rate (2022 - 2025)

Gyre Therapeutics (GYRE) has disclosed Tax Rate for 7 consecutive years, with 19.44% as the latest value for Q1 2025.

  • On a quarterly basis, Tax Rate changed N/A to 19.44% in Q1 2025 year-over-year; TTM through Mar 2025 was 91.77%, a N/A change, with the full-year FY2024 number at 39.11%, up 5018.0% from a year prior.
  • Tax Rate was 19.44% for Q1 2025 at Gyre Therapeutics, down from 181.2% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 749.64% in Q1 2023 to a low of 26.26% in Q4 2022.
  • A 4-year average of 133.39% and a median of 22.41% in 2025 define the central range for Tax Rate.
  • Biggest YoY gain for Tax Rate was 19281bps in 2024; the steepest drop was -10407bps in 2024.
  • Gyre Therapeutics' Tax Rate stood at 26.26% in 2022, then surged by 56bps to 11.61% in 2023, then skyrocketed by 1661bps to 181.2% in 2024, then plummeted by -89bps to 19.44% in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Tax Rate are 19.44% (Q1 2025), 181.2% (Q4 2024), and 25.37% (Q3 2024).